Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism.

Geller DS, Zhang J, Wisgerhof MV, Shackleton C, Kashgarian M, Lifton RP.

J Clin Endocrinol Metab. 2008 Aug;93(8):3117-23. doi: 10.1210/jc.2008-0594. Epub 2008 May 27.

2.

Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism.

Lee IS, Kim SY, Jang HW, Kim MK, Lee JH, Lee YH, Jo YS.

J Korean Med Sci. 2010 Sep;25(9):1379-83. doi: 10.3346/jkms.2010.25.9.1379. Epub 2010 Aug 14.

3.

Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.

Fardella CE, Pinto M, Mosso L, Gómez-Sánchez C, Jalil J, Montero J.

J Clin Endocrinol Metab. 2001 Oct;86(10):4805-7.

PMID:
11600544
4.

A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.

Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM.

Nature. 1992 Jan 16;355(6357):262-5.

PMID:
1731223
5.

Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children.

Kamrath C, Maser-Gluth C, Haag C, Schulze E.

Horm Res Paediatr. 2011;76(2):93-8. doi: 10.1159/000326524. Epub 2011 May 27.

PMID:
21625068
6.

Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.

Fallo F, Pilon C, Williams TA, Sonino N, Morra Di Cella S, Veglio F, De Iasio R, Montanari P, Mulatero P.

J Hum Hypertens. 2004 Jan;18(1):47-51.

PMID:
14688810
7.

Familial hyperaldosteronism.

Torpy DJ, Stratakis CA, Chrousos GP.

Braz J Med Biol Res. 2000 Oct;33(10):1149-55. Review.

8.

Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.

Fardella CE, Mosso L, Gómez-Sánchez C, Cortés P, Soto J, Gómez L, Pinto M, Huete A, Oestreicher E, Foradori A, Montero J.

J Clin Endocrinol Metab. 2000 May;85(5):1863-7.

PMID:
10843166
9.

High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.

Stowasser M, Gordon RD, Gunasekera TG, Cowley DC, Ward G, Archibald C, Smithers BM.

J Hypertens. 2003 Nov;21(11):2149-57.

PMID:
14597859
10.

Glucocorticoid remediable aldosteronism: a case report.

Hsieh CJ, Wang PW, Liu JC, Tung SC, Chien WY, Lu YC, Kuo MC.

Changgeng Yi Xue Za Zhi. 1997 Mar;20(1):52-7.

PMID:
9178594
11.

Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications.

Carroll J, Dluhy R, Fallo F, Pistorello M, Bradwin G, Gomez-Sanchez CE, Mortensen R.

J Clin Endocrinol Metab. 1996 Dec;81(12):4310-2.

PMID:
8954032
12.

[Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].

Szücs N, Gláz E, Varga I, Tóth M, Kiss R, Patócs A, Jakab C, Perner F, Járay J, Horányi J, Dabasi G, Molnár F, Major L, Füto L, Rácz K, Tulassay Z.

Orv Hetil. 2006 Jan 15;147(2):51-9. Hungarian.

PMID:
16509213
13.

Is altered adrenal steroid biosynthesis a key intermediate phenotype in hypertension?

Connell JM, Fraser R, MacKenzie S, Davies E.

Hypertension. 2003 May;41(5):993-9. Epub 2003 Mar 24. Review.

14.

Glucocorticoid-remediable aldosteronism.

Halperin F, Dluhy RG.

Endocrinol Metab Clin North Am. 2011 Jun;40(2):333-41, viii. doi: 10.1016/j.ecl.2011.01.012.

PMID:
21565670
15.

New genetic insights in familial hyperaldosteronism.

Jackson RV, Lafferty A, Torpy DJ, Stratakis C.

Ann N Y Acad Sci. 2002 Sep;970:77-88. Review.

PMID:
12381543
16.

The molecular basis of glucocorticoid-remediable aldosteronism, a Mendelian cause of human hypertension.

Lifton RP, Dluhy RG, Powers M, Ulick S, Lalouel JM.

Trans Assoc Am Physicians. 1992;105:64-71. No abstract available.

PMID:
1309006
17.

Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree.

Mulatero P, di Cella SM, Williams TA, Milan A, Mengozzi G, Chiandussi L, Gomez-Sanchez CE, Veglio F.

J Clin Endocrinol Metab. 2002 Jul;87(7):3187-91.

PMID:
12107222
18.

Glucocorticoid-suppressible aldosteronism: a disorder of the adrenal transitional zone.

Gomez-Sanchez CE, Gill JR Jr, Ganguly A, Gordon RD.

J Clin Endocrinol Metab. 1988 Sep;67(3):444-8.

PMID:
2842358
19.

Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol.

Mulatero P, Curnow KM, Aupetit-Faisant B, Foekling M, Gomez-Sanchez C, Veglio F, Jeunemaitre X, Corvol P, Pascoe L.

J Clin Endocrinol Metab. 1998 Nov;83(11):3996-4001.

PMID:
9814482
20.

Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism.

Litchfield WR, New MI, Coolidge C, Lifton RP, Dluhy RG.

J Clin Endocrinol Metab. 1997 Nov;82(11):3570-3.

PMID:
9360508

Supplemental Content

Support Center